HEADER TRANSFERASE 15-MAY-08 2VTT TITLE IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H- TITLE 2 PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE TITLE 3 INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE TITLE 4 BASED DRUG DESIGN. COMPND MOL_ID: 1; COMPND 2 MOLECULE: CELL DIVISION PROTEIN KINASE 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: P33 PROTEIN KINASE, CDK2; COMPND 5 EC: 2.7.11.1, 2.7.11.22; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE, MITOSIS, CELL CYCLE, SERINE/THREONINE PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR P.G.WYATT,A.J.WOODHEAD,J.A.BOULSTRIDGE,V.BERDINI,M.G.CARR,D.M.CROSS, AUTHOR 2 D.DANILLON,D.J.DAVIS,L.A.DEVINE,T.R.EARLY,R.E.FELTELL,E.J.LEWIS, AUTHOR 3 R.L.MCMENAMIN,E.F.NAVARRO,M.A.O'BRIEN,M.O'REILLY,M.REULE,G.SAXTY, AUTHOR 4 L.C.A.SEAVERS,D.SMITH,M.S.SQUIRES,G.TREWARTHA,M.T.WALKER, AUTHOR 5 A.J.WOOLFORD REVDAT 5 01-MAY-24 2VTT 1 REMARK REVDAT 4 20-JUN-18 2VTT 1 JRNL REVDAT 3 03-NOV-10 2VTT 1 VERSN J RNL REVDAT 2 24-FEB-09 2VTT 1 VERSN REVDAT 1 05-AUG-08 2VTT 0 JRNL AUTH P.G.WYATT,A.J.WOODHEAD,V.BERDINI,J.A.BOULSTRIDGE,M.G.CARR, JRNL AUTH 2 D.M.CROSS,D.J.DAVIS,L.A.DEVINE,T.R.EARLY,R.E.FELTELL, JRNL AUTH 3 E.J.LEWIS,R.L.MCMENAMIN,E.F.NAVARRO,M.A.O'BRIEN,M.O'REILLY, JRNL AUTH 4 M.REULE,G.SAXTY,L.C.A.SEAVERS,D.SMITH,M.S.SQUIRES, JRNL AUTH 5 G.TREWARTHA,M.T.WALKER,A.J.WOOLFORD JRNL TITL IDENTIFICATION OF JRNL TITL 2 N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO) JRNL TITL 3 -1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN JRNL TITL 4 DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY JRNL TITL 5 CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. JRNL REF J.MED.CHEM. V. 51 4986 2008 JRNL REFN ISSN 0022-2623 JRNL PMID 18656911 JRNL DOI 10.1021/JM800382H REMARK 2 REMARK 2 RESOLUTION. 1.68 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.1.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.68 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 76.2 REMARK 3 NUMBER OF REFLECTIONS : 24602 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.960 REMARK 3 FREE R VALUE TEST SET COUNT : 1220 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.68 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.78 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 76.19 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 975 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2409 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 920 REMARK 3 BIN R VALUE (WORKING SET) : 0.2402 REMARK 3 BIN FREE R VALUE : 0.2534 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.64 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 55 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2195 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 218 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.93 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.88 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.78749 REMARK 3 B22 (A**2) : -3.48394 REMARK 3 B33 (A**2) : 2.69645 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2VTT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-MAY-08. REMARK 100 THE DEPOSITION ID IS D_1290036265. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200HR REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC CONFOCAL BLUE REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24602 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.680 REMARK 200 RESOLUTION RANGE LOW (A) : 43.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 76.2 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.03000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.6800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.68 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 12.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.24000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: IN-HOUSE STRUCTURE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES/NAOH, PH7.0, 0.0475M REMARK 280 AMMONIUM ACETATE, 12% W/V PEG 3350, PH 6.7 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.78350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.05800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.73800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 36.05800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.78350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.73800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 36 REMARK 465 LEU A 37 REMARK 465 ASP A 38 REMARK 465 THR A 39 REMARK 465 GLU A 40 REMARK 465 THR A 41 REMARK 465 GLU A 42 REMARK 465 GLY A 43 REMARK 465 VAL A 44 REMARK 465 PRO A 45 REMARK 465 SER A 46 REMARK 465 ALA A 149 REMARK 465 ARG A 150 REMARK 465 ALA A 151 REMARK 465 PHE A 152 REMARK 465 GLY A 153 REMARK 465 VAL A 154 REMARK 465 PRO A 155 REMARK 465 VAL A 156 REMARK 465 ARG A 157 REMARK 465 THR A 158 REMARK 465 TYR A 159 REMARK 465 THR A 160 REMARK 465 HIS A 161 REMARK 465 GLU A 162 REMARK 465 VAL A 163 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2015 O HOH A 2026 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 166 CB - CG - CD1 ANGL. DEV. = -10.5 DEGREES REMARK 500 PRO A 253 C - N - CA ANGL. DEV. = -10.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 14 -91.88 -35.98 REMARK 500 GLU A 73 38.78 35.67 REMARK 500 ARG A 126 -27.21 81.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2019 DISTANCE = 6.79 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LZD A 1299 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1PYE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CDK2 WITH INHIBITOR REMARK 900 RELATED ID: 1H08 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4 -BIS ANILINO PYRIMIDINE REMARK 900 CDK4 INHIBITOR REMARK 900 RELATED ID: 2B53 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DIN-234325 REMARK 900 RELATED ID: 1V1K RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE REMARK 900 CDK4 INHIBITOR REMARK 900 RELATED ID: 1OKV RELATED DB: PDB REMARK 900 CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ILE-PHE-NH2 REMARK 900 RELATED ID: 1KE7 RELATED DB: PDB REMARK 900 CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[(2,2-DIOXIDO-1, REMARK 900 3-DIHYDRO-2- BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3- OXAZOL-5-YL)- REMARK 900 1,3-DIHYDRO-2H-INDOL-2-ONE REMARK 900 RELATED ID: 1H25 RELATED DB: PDB REMARK 900 CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM REMARK 900 E2F REMARK 900 RELATED ID: 1PXK RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR N-[4-(2, REMARK 900 4-DIMETHYL- THIAZOL-5-YL)PYRIMIDIN-2-YL]-N'- HYDROXYIMINOFORMAMIDE REMARK 900 RELATED ID: 2BHH RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE REMARK 900 INHIBITOR 4- HYDROXYPIPERINDINESULFONYL-INDIRUBINE REMARK 900 RELATED ID: 2VTA RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2UUE RELATED DB: PDB REMARK 900 REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE REMARK 900 INHIBITORS REMARK 900 RELATED ID: 1E1V RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU2058 REMARK 900 RELATED ID: 1GZ8 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 2- REMARK 900 AMINO-6-(3'-METHYL- 2'-OXO)BUTOXYPURINE REMARK 900 RELATED ID: 1OL2 RELATED DB: PDB REMARK 900 CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ASN-(P-F-PHE)-NH2 REMARK 900 RELATED ID: 1H27 RELATED DB: PDB REMARK 900 CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM REMARK 900 P27 REMARK 900 RELATED ID: 1JSV RELATED DB: PDB REMARK 900 THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) INCOMPLEX WITH 4- REMARK 900 [(6-AMINO-4- PYRIMIDINYL)AMINO]BENZENESULFONAMIDE REMARK 900 RELATED ID: 2B52 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DPH-042562 REMARK 900 RELATED ID: 1KE5 RELATED DB: PDB REMARK 900 CDK2 COMPLEXED WITH N-METHYL-4-{[(2-OXO- 1,2-DIHYDRO-3H-INDOL-3- REMARK 900 YLIDENE)METHYL] AMINO}BENZENESULFONAMIDE REMARK 900 RELATED ID: 1FIN RELATED DB: PDB REMARK 900 CYCLIN A - CYCLIN-DEPENDENT KINASE 2 COMPLEX REMARK 900 RELATED ID: 2C5O RELATED DB: PDB REMARK 900 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 REMARK 900 PROVIDES INSIGHTS FOR DRUG DESIGN REMARK 900 RELATED ID: 2C68 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1P2A RELATED DB: PDB REMARK 900 THE STRUCTURE OF CYCLIN DEPENDENT KINASE 2 (CKD2) WITH REMARK 900 ATRISUBSTITUTED NAPHTHOSTYRIL INHIBITOR REMARK 900 RELATED ID: 2C4G RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514 REMARK 900 RELATED ID: 1W0X RELATED DB: PDB REMARK 900 CRYSTALS STRUCTURE OF HUMAN CDK2 IN COMPLEX WITH THE INHIBITOR REMARK 900 OLOMOUCINE. REMARK 900 RELATED ID: 1H1Q RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE REMARK 900 INHIBITOR NU6094 REMARK 900 RELATED ID: 1PXO RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR [4-(2- REMARK 900 AMINO-4-METHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(3-NITRO- PHENYL)- REMARK 900 AMINE REMARK 900 RELATED ID: 1KE9 RELATED DB: PDB REMARK 900 CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4-({ REMARK 900 [AMINO(IMINO)METHYL] AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3- REMARK 900 DIHYDRO-1H-INDOLE REMARK 900 RELATED ID: 2A0C RELATED DB: PDB REMARK 900 HUMAN CDK2 IN COMPLEX WITH OLOMOUCINE II, A NOVEL 2,6,9- REMARK 900 TRISUBSTITUTED PURINE CYCLIN -DEPENDENT KINASE INHIBITOR REMARK 900 RELATED ID: 1HCK RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 REMARK 900 RELATED ID: 1JSU RELATED DB: PDB REMARK 900 P27(KIP1)/CYCLIN A/CDK2 COMPLEX REMARK 900 RELATED ID: 1PXN RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-[4-(4- REMARK 900 METHYL-2- METHYLAMINO-THIAZOL-5-YL)-PYRIMIDIN-2- YLAMINO]-PHENOL REMARK 900 RELATED ID: 2UZE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2V0D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1OIQ RELATED DB: PDB REMARK 900 IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT REMARK 900 KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION REMARK 900 RELATED ID: 1H1R RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE REMARK 900 INHIBITOR NU6086 REMARK 900 RELATED ID: 2IW8 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A F82H-L83V-H84D REMARK 900 MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR REMARK 900 RELATED ID: 1HCL RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 REMARK 900 RELATED ID: 1GIH RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR REMARK 900 RELATED ID: 1PW2 RELATED DB: PDB REMARK 900 APO STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2 REMARK 900 RELATED ID: 1JST RELATED DB: PDB REMARK 900 PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A REMARK 900 RELATED ID: 1OIU RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- REMARK 900 CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR REMARK 900 RELATED ID: 1PXM RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 3-[4-(2, REMARK 900 4-DIMETHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINO]-PHENOL REMARK 900 RELATED ID: 1B38 RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 REMARK 900 RELATED ID: 1FQ1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) INCOMPLEX REMARK 900 WITH PHOSPHO-CDK2 REMARK 900 RELATED ID: 1VYW RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137 REMARK 900 RELATED ID: 1H1P RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE REMARK 900 INHIBITOR NU2058 REMARK 900 RELATED ID: 2C69 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1URC RELATED DB: PDB REMARK 900 CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ASN-(P-F-PHE)-NH2 REMARK 900 RELATED ID: 1PXI RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-(2,5- REMARK 900 DICHLORO-THIOPHEN- 3-YL)-PYRIMIDIN-2-YLAMINE REMARK 900 RELATED ID: 2C6I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1YKR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CDK2 WITH AN AMINOIMIDAZO PYRIDINEINHIBITOR REMARK 900 RELATED ID: 2C6K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 2UZD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2C5Y RELATED DB: PDB REMARK 900 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 REMARK 900 PROVIDES INSIGHTS FOR DRUG DESIGN REMARK 900 RELATED ID: 1WCC RELATED DB: PDB REMARK 900 SCREENING FOR FRAGMENT BINDING BY X-RAY CRYSTALLOGRAPHY REMARK 900 RELATED ID: 2J9M RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CDK2 IN COMPLEX WITH MACROCYCLIC REMARK 900 AMINOPYRIMIDINE REMARK 900 RELATED ID: 1VYZ RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 COMPLEXED WITH PNU-181227 REMARK 900 RELATED ID: 1JVP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 ( UNPHOSPHORYLATED) INCOMPLEX WITH REMARK 900 PKF049-365 REMARK 900 RELATED ID: 1W98 RELATED DB: PDB REMARK 900 THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E REMARK 900 RELATED ID: 1PKD RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO-CDK2/CYCLIN REMARK 900 A REMARK 900 RELATED ID: 1P5E RELATED DB: PDB REMARK 900 THE STRUCURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THEINHIBITOR REMARK 900 4,5,6,7- TETRABROMOBENZOTRIAZOLE (TBS) REMARK 900 RELATED ID: 2C5P RELATED DB: PDB REMARK 900 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 REMARK 900 PROVIDES INSIGHTS FOR DRUG DESIGN REMARK 900 RELATED ID: 2UZN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2B54 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 (CKD2) COMPLEXED WITH DIN-232305 REMARK 900 RELATED ID: 1KE6 RELATED DB: PDB REMARK 900 CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH N-METHYL-{4-[2-(7- REMARK 900 OXO-6,7-DIHYDRO -8H-[1,3]THIAZOLO[5,4-E]INDOL-8- YLIDENE)HYDRAZINO] REMARK 900 PHENYL}METHANESULFONAMIDE REMARK 900 RELATED ID: 1PXJ RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-(2,4- REMARK 900 DIMETHYL-THIAZOL- 5-YL)-PYRIMIDIN-2-YLAMINE REMARK 900 RELATED ID: 2UZL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2CCI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITH A REMARK 900 PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6 REMARK 900 RELATED ID: 2BKZ RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611 REMARK 900 RELATED ID: 2G9X RELATED DB: PDB REMARK 900 STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/ CYCLIN A INCOMPLEX WITH REMARK 900 THE INHIBITOR NU6271 REMARK 900 RELATED ID: 1Y91 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1,5-A] REMARK 900 PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 2IW6 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A COMPLEXED WITH A REMARK 900 BISANILINOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1GIJ RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR REMARK 900 RELATED ID: 1R78 RELATED DB: PDB REMARK 900 CDK2 COMPLEX WITH A 4-ALKYNYL OXINDOLE INHIBITOR REMARK 900 RELATED ID: 1H0V RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE REMARK 900 INHIBITOR 2-AMINO-6-[(R )-PYRROLIDINO-5'-YL]METHOXYPURINE REMARK 900 RELATED ID: 2IW9 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A COMPLEXED WITH A REMARK 900 BISANILINOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1W8C RELATED DB: PDB REMARK 900 CO-CRYSTAL STRUCTURE OF 6-CYCLOHEXYLMETHOXY- 8-ISOPROPYL-9H-PURIN-2- REMARK 900 YLAMINE AND MONOMERIC CDK2 REMARK 900 RELATED ID: 1BUH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITHCELL CYCLE- REMARK 900 REGULATORY PROTEIN CKSHS1 REMARK 900 RELATED ID: 2BPM RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529 REMARK 900 RELATED ID: 2BTS RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032 REMARK 900 RELATED ID: 1FVV RELATED DB: PDB REMARK 900 THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLEINHIBITOR REMARK 900 RELATED ID: 1OKW RELATED DB: PDB REMARK 900 CYCLIN A BINDING GROOVE INHIBITOR AC-ARG- ARG-LEU-ASN-(M-CL-PHE)-NH2 REMARK 900 RELATED ID: 2A4L RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 IN COMPLEX WITH ROSCOVITINE REMARK 900 RELATED ID: 2C6T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1FVT RELATED DB: PDB REMARK 900 THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) INCOMPLEX WITH AN REMARK 900 OXINDOLE INHIBITOR REMARK 900 RELATED ID: 1QMZ RELATED DB: PDB REMARK 900 PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX REMARK 900 RELATED ID: 1OGU RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 2- REMARK 900 ARYLAMINO-4- CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 2B55 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITHINDENOPYRAXOLE REMARK 900 DIN-101312 REMARK 900 RELATED ID: 1PF8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2COMPLEXED WITH REMARK 900 A NUCLEOSIDE INHIBITOR REMARK 900 RELATED ID: 1H1S RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE REMARK 900 INHIBITOR NU6102 REMARK 900 RELATED ID: 2C5V RELATED DB: PDB REMARK 900 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 REMARK 900 PROVIDES INSIGHTS FOR DRUG DESIGN REMARK 900 RELATED ID: 2JGZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PHOSPHO-CDK2 IN COMPLEX WITH CYCLIN B REMARK 900 RELATED ID: 2BHE RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE REMARK 900 INHIBITOR 5-BROMO- INDIRUBINE REMARK 900 RELATED ID: 1URW RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH AN IMIDAZO[1,2-B] PYRIDAZINE REMARK 900 RELATED ID: 1OIY RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- REMARK 900 CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR REMARK 900 RELATED ID: 2C6L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1F5Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO REMARK 900 HUMAN CYCLIN DEPENDANT KINASE 2 REMARK 900 RELATED ID: 2C6O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1OL1 RELATED DB: PDB REMARK 900 CYCLIN A BINDING GROOVE INHIBITOR H-CIT- CIT-LEU-ILE-(P-F-PHE)-NH2 REMARK 900 RELATED ID: 2UZB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1H01 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4 -BIS ANILINO PYRIMIDINE REMARK 900 CDK4 INHIBITOR REMARK 900 RELATED ID: 1OIR RELATED DB: PDB REMARK 900 IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT REMARK 900 KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION REMARK 900 RELATED ID: 1OI9 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- REMARK 900 CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR REMARK 900 RELATED ID: 2CJM RELATED DB: PDB REMARK 900 MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATION: CDK2 REMARK 900 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE REMARK 900 RELATED ID: 2C5N RELATED DB: PDB REMARK 900 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 REMARK 900 PROVIDES INSIGHTS FOR DRUG DESIGN REMARK 900 RELATED ID: 2C5X RELATED DB: PDB REMARK 900 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 REMARK 900 PROVIDES INSIGHTS FOR DRUG DESIGN REMARK 900 RELATED ID: 2C6M RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1OIT RELATED DB: PDB REMARK 900 IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT REMARK 900 KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION REMARK 900 RELATED ID: 2V22 RELATED DB: PDB REMARK 900 REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE REMARK 900 INHIBITORS REMARK 900 RELATED ID: 1GY3 RELATED DB: PDB REMARK 900 PCDK2/CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE SUBSTRATE REMARK 900 RELATED ID: 1GII RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR REMARK 900 RELATED ID: 1DI8 RELATED DB: PDB REMARK 900 THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4- REMARK 900 [3- HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE REMARK 900 RELATED ID: 1E9H RELATED DB: PDB REMARK 900 THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE REMARK 900 INHIBITOR INDIRUBIN-5- SULPHONATE BOUND REMARK 900 RELATED ID: 1DM2 RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR REMARK 900 HYMENIALDISINE REMARK 900 RELATED ID: 2UZO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1H24 RELATED DB: PDB REMARK 900 CDK2/CYCLINA IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM REMARK 900 E2F REMARK 900 RELATED ID: 1H00 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE REMARK 900 CDK4 INHIBITOR REMARK 900 RELATED ID: 2EXM RELATED DB: PDB REMARK 900 HUMAN CDK2 IN COMPLEX WITH ISOPENTENYLADENINE REMARK 900 RELATED ID: 2CLX RELATED DB: PDB REMARK 900 4-ARYLAZO-3,5-DIAMINO-1H-PYRAZOLE CDK INHIBITORS: SAR STUDY, REMARK 900 CRYSTAL STRUCTURE IN COMPLEX WITH CDK2, SELECTIVITY, AND CELLULAR REMARK 900 EFFECTS REMARK 900 RELATED ID: 1PXP RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR N-[4-(2, REMARK 900 4-DIMETHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'- DIMETHYL-BENZENE-1, REMARK 900 4-DIAMINE REMARK 900 RELATED ID: 2CCH RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE REMARK 900 PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE REMARK 900 RELATED ID: 1B39 RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 PHOSPHORYLATED ON THR 160 REMARK 900 RELATED ID: 2BTR RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873 REMARK 900 RELATED ID: 1AQ1 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR REMARK 900 STAUROSPORINE REMARK 900 RELATED ID: 1H0W RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE REMARK 900 INHIBITOR 2-AMINO-6-[ CYCLOHEX-3-ENYL]METHOXYPURINE REMARK 900 RELATED ID: 1G5S RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2)IN REMARK 900 COMPLEX WITH THE INHIBITOR H717 REMARK 900 RELATED ID: 1CKP RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR REMARK 900 PURVALANOL B REMARK 900 RELATED ID: 1PXL RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR [4-(2,4- REMARK 900 DIMETHYL-THIAZOL- 5-YL)-PYRIMIDIN-2-YL]-(4-TRIFLUOROMETHYL- PHENYL)- REMARK 900 AMINE REMARK 900 RELATED ID: 1KE8 RELATED DB: PDB REMARK 900 CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 4-{[(2-OXO-1,2- REMARK 900 DIHYDRO-3H-INDOL-3 -YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2- YL) REMARK 900 BENZENESULFONAMIDE REMARK 900 RELATED ID: 1H28 RELATED DB: PDB REMARK 900 CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM REMARK 900 P107 REMARK 900 RELATED ID: 1H26 RELATED DB: PDB REMARK 900 CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM REMARK 900 P53 REMARK 900 RELATED ID: 1H07 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE REMARK 900 CDK4 INHIBITOR REMARK 900 RELATED ID: 1E1X RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027 REMARK 900 RELATED ID: 1Y8Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1,5-A] REMARK 900 PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 2VTH RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2VTI RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2VTJ RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2VTL RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2VTM RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2VTN RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2VTO RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2VTP RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2VTQ RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2VTR RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2VTS RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. DBREF 2VTT A 1 298 UNP P24941 CDK2_HUMAN 1 298 SEQRES 1 A 298 MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY GLU GLY SEQRES 2 A 298 THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS LEU THR SEQRES 3 A 298 GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU ASP THR SEQRES 4 A 298 GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG GLU ILE SEQRES 5 A 298 SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE VAL LYS SEQRES 6 A 298 LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU TYR LEU SEQRES 7 A 298 VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS PHE MET SEQRES 8 A 298 ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO LEU ILE SEQRES 9 A 298 LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU ALA PHE SEQRES 10 A 298 CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU LYS PRO SEQRES 11 A 298 GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE LYS LEU SEQRES 12 A 298 ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL PRO VAL SEQRES 13 A 298 ARG THR TYR THR HIS GLU VAL VAL THR LEU TRP TYR ARG SEQRES 14 A 298 ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SER THR SEQRES 15 A 298 ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE ALA GLU SEQRES 16 A 298 MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SER GLU SEQRES 17 A 298 ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU GLY THR SEQRES 18 A 298 PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER MET PRO SEQRES 19 A 298 ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG GLN ASP SEQRES 20 A 298 PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP GLY ARG SEQRES 21 A 298 SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO ASN LYS SEQRES 22 A 298 ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO PHE PHE SEQRES 23 A 298 GLN ASP VAL THR LYS PRO VAL PRO HIS LEU ARG LEU HET LZD A1299 25 HETNAM LZD 4-{[(2,6-DIFLUOROPHENYL)CARBONYL]AMINO}-N-[(3S)- HETNAM 2 LZD PIPERIDIN-3-YL]-1H-PYRAZOLE-3-CARBOXAMIDE FORMUL 2 LZD C16 H17 F2 N5 O2 FORMUL 3 HOH *218(H2 O) HELIX 1 1 THR A 47 LYS A 56 1 10 HELIX 2 2 LEU A 87 SER A 94 1 8 HELIX 3 3 PRO A 100 HIS A 121 1 22 HELIX 4 4 LYS A 129 GLN A 131 5 3 HELIX 5 5 ALA A 170 LEU A 175 1 6 HELIX 6 6 THR A 182 ARG A 199 1 18 HELIX 7 7 SER A 207 GLY A 220 1 14 HELIX 8 8 GLY A 229 MET A 233 5 5 HELIX 9 9 ASP A 247 VAL A 252 1 6 HELIX 10 10 ASP A 256 LEU A 267 1 12 HELIX 11 11 SER A 276 ALA A 282 1 7 HELIX 12 12 HIS A 283 GLN A 287 5 5 SHEET 1 AA 5 PHE A 4 GLY A 11 0 SHEET 2 AA 5 VAL A 17 ASN A 23 -1 O VAL A 18 N ILE A 10 SHEET 3 AA 5 VAL A 29 ILE A 35 -1 O VAL A 30 N ALA A 21 SHEET 4 AA 5 LYS A 75 GLU A 81 -1 O LEU A 76 N ILE A 35 SHEET 5 AA 5 LEU A 66 THR A 72 -1 N LEU A 67 O VAL A 79 SHEET 1 AB 3 GLN A 85 ASP A 86 0 SHEET 2 AB 3 LEU A 133 ILE A 135 -1 O ILE A 135 N GLN A 85 SHEET 3 AB 3 ILE A 141 LEU A 143 -1 O LYS A 142 N LEU A 134 CISPEP 1 PRO A 253 PRO A 254 0 11.13 SITE 1 AC1 14 ILE A 10 VAL A 18 ALA A 31 LYS A 33 SITE 2 AC1 14 GLU A 81 PHE A 82 LEU A 83 HIS A 84 SITE 3 AC1 14 ASP A 86 LEU A 134 ASP A 145 HOH A2103 SITE 4 AC1 14 HOH A2217 HOH A2218 CRYST1 53.567 71.476 72.116 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018668 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013991 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013867 0.00000 TER 2196 LEU A 298 HETATM 2197 C2 LZD A1299 33.000 9.661 65.065 1.00 20.47 C HETATM 2198 C3 LZD A1299 32.327 9.372 66.403 1.00 19.93 C HETATM 2199 C4 LZD A1299 31.588 8.039 66.369 1.00 23.33 C HETATM 2200 C5 LZD A1299 30.588 8.014 65.213 1.00 22.77 C HETATM 2201 N6 LZD A1299 29.880 6.733 65.139 1.00 18.90 N HETATM 2202 C7 LZD A1299 28.643 6.657 64.598 1.00 23.41 C HETATM 2203 O8 LZD A1299 28.066 7.635 64.130 1.00 24.09 O HETATM 2204 C9 LZD A1299 28.011 5.323 64.560 1.00 24.84 C HETATM 2205 N10 LZD A1299 28.467 4.259 65.277 1.00 22.87 N HETATM 2206 N11 LZD A1299 27.634 3.232 64.962 1.00 22.44 N HETATM 2207 C12 LZD A1299 26.671 3.618 64.094 1.00 22.40 C HETATM 2208 C13 LZD A1299 26.899 4.962 63.810 1.00 24.67 C HETATM 2209 N14 LZD A1299 26.230 5.835 62.963 1.00 19.52 N HETATM 2210 C15 LZD A1299 25.284 5.499 62.066 1.00 16.88 C HETATM 2211 O16 LZD A1299 24.809 4.363 61.981 1.00 17.61 O HETATM 2212 C17 LZD A1299 24.831 6.597 61.158 1.00 23.03 C HETATM 2213 C18 LZD A1299 25.721 7.234 60.286 1.00 28.93 C HETATM 2214 F19 LZD A1299 27.013 6.846 60.285 1.00 28.33 F HETATM 2215 C20 LZD A1299 25.299 8.258 59.436 1.00 29.70 C HETATM 2216 C21 LZD A1299 23.969 8.647 59.443 1.00 27.01 C HETATM 2217 C22 LZD A1299 23.071 8.022 60.298 1.00 31.84 C HETATM 2218 C23 LZD A1299 23.514 7.003 61.141 1.00 28.27 C HETATM 2219 F24 LZD A1299 22.650 6.398 61.977 1.00 28.36 F HETATM 2220 C25 LZD A1299 31.295 8.335 63.884 1.00 23.63 C HETATM 2221 N26 LZD A1299 31.997 9.648 63.962 1.00 23.73 N HETATM 2222 O HOH A2001 23.476 14.064 77.347 1.00 70.47 O HETATM 2223 O HOH A2002 33.411 13.425 71.337 1.00 49.83 O HETATM 2224 O HOH A2003 31.387 9.657 70.046 1.00 39.87 O HETATM 2225 O HOH A2004 32.634 11.830 69.086 1.00 33.66 O HETATM 2226 O HOH A2005 33.871 10.267 72.738 1.00 44.60 O HETATM 2227 O HOH A2006 30.826 13.340 76.204 1.00 52.98 O HETATM 2228 O HOH A2007 26.294 16.084 72.571 1.00 42.37 O HETATM 2229 O HOH A2008 23.134 14.772 74.483 1.00 65.16 O HETATM 2230 O HOH A2009 21.966 11.435 60.529 1.00 45.59 O HETATM 2231 O HOH A2010 23.688 23.167 60.421 1.00 50.32 O HETATM 2232 O HOH A2011 13.448 14.823 55.294 1.00 70.89 O HETATM 2233 O HOH A2012 31.902 7.974 75.985 1.00 39.26 O HETATM 2234 O HOH A2013 33.204 7.863 71.479 1.00 28.31 O HETATM 2235 O HOH A2014 27.827 -13.801 53.095 1.00 41.01 O HETATM 2236 O HOH A2015 38.177 -8.372 56.233 1.00 64.66 O HETATM 2237 O HOH A2016 21.267 -2.106 73.089 1.00 44.05 O HETATM 2238 O HOH A2017 28.038 -1.421 70.136 1.00 23.05 O HETATM 2239 O HOH A2018 28.601 -2.064 73.818 1.00 26.89 O HETATM 2240 O HOH A2019 25.842 30.087 40.316 1.00 43.22 O HETATM 2241 O HOH A2020 32.373 20.791 52.187 1.00 39.52 O HETATM 2242 O HOH A2021 35.489 17.210 52.902 1.00 40.98 O HETATM 2243 O HOH A2022 40.957 16.439 61.892 1.00 48.34 O HETATM 2244 O HOH A2023 49.662 15.216 60.471 1.00 40.31 O HETATM 2245 O HOH A2024 52.920 2.123 53.912 1.00 51.21 O HETATM 2246 O HOH A2025 51.922 -1.095 49.059 1.00 61.02 O HETATM 2247 O HOH A2026 40.211 -7.877 55.573 1.00 43.39 O HETATM 2248 O HOH A2027 41.995 -8.990 53.194 1.00 77.81 O HETATM 2249 O HOH A2028 21.729 -4.219 58.435 1.00 22.57 O HETATM 2250 O HOH A2029 24.977 -14.130 51.209 1.00 51.80 O HETATM 2251 O HOH A2030 18.686 -8.292 63.831 1.00 49.78 O HETATM 2252 O HOH A2031 17.047 -10.802 62.351 1.00 81.48 O HETATM 2253 O HOH A2032 21.886 -12.836 60.366 1.00 42.18 O HETATM 2254 O HOH A2033 26.562 -12.682 59.102 1.00 28.58 O HETATM 2255 O HOH A2034 22.956 -5.609 60.716 1.00 24.14 O HETATM 2256 O HOH A2035 19.488 -10.653 63.030 1.00 42.69 O HETATM 2257 O HOH A2036 27.900 -10.416 60.134 1.00 25.61 O HETATM 2258 O HOH A2037 31.794 -11.020 52.099 1.00 27.24 O HETATM 2259 O HOH A2038 34.291 -6.384 60.427 1.00 32.99 O HETATM 2260 O HOH A2039 35.347 -8.381 55.265 1.00 37.17 O HETATM 2261 O HOH A2040 28.589 -7.922 63.015 1.00 39.94 O HETATM 2262 O HOH A2041 25.716 -6.430 60.047 1.00 19.29 O HETATM 2263 O HOH A2042 22.450 -1.684 59.094 1.00 26.60 O HETATM 2264 O HOH A2043 20.958 -7.607 63.112 1.00 31.51 O HETATM 2265 O HOH A2044 14.102 -4.976 67.257 1.00 40.73 O HETATM 2266 O HOH A2045 6.066 -0.613 70.887 1.00 50.08 O HETATM 2267 O HOH A2046 20.421 2.794 35.761 1.00 44.82 O HETATM 2268 O HOH A2047 3.941 5.369 67.379 1.00 70.38 O HETATM 2269 O HOH A2048 25.801 -5.580 38.464 1.00 42.40 O HETATM 2270 O HOH A2049 31.847 -4.473 67.398 1.00 42.92 O HETATM 2271 O HOH A2050 37.726 20.138 47.487 1.00 67.44 O HETATM 2272 O HOH A2051 34.731 8.100 69.204 1.00 38.92 O HETATM 2273 O HOH A2052 35.141 1.139 67.463 1.00 21.66 O HETATM 2274 O HOH A2053 36.371 11.341 65.138 1.00 59.13 O HETATM 2275 O HOH A2054 41.833 9.296 63.842 1.00 56.03 O HETATM 2276 O HOH A2055 22.706 26.565 45.550 1.00 43.24 O HETATM 2277 O HOH A2056 25.137 27.695 42.814 1.00 45.92 O HETATM 2278 O HOH A2057 33.591 19.015 55.028 1.00 54.19 O HETATM 2279 O HOH A2058 39.373 14.580 62.033 1.00 30.13 O HETATM 2280 O HOH A2059 31.908 12.945 59.818 1.00 48.10 O HETATM 2281 O HOH A2060 43.213 12.095 53.578 1.00 38.60 O HETATM 2282 O HOH A2061 36.879 18.023 55.155 1.00 53.62 O HETATM 2283 O HOH A2062 36.869 15.891 60.720 1.00 59.70 O HETATM 2284 O HOH A2063 43.923 18.117 59.480 1.00 61.88 O HETATM 2285 O HOH A2064 37.206 14.035 54.658 1.00 41.84 O HETATM 2286 O HOH A2065 46.099 16.512 59.259 1.00 61.76 O HETATM 2287 O HOH A2066 20.244 14.751 21.507 1.00 47.56 O HETATM 2288 O HOH A2067 46.408 7.568 58.009 1.00 35.32 O HETATM 2289 O HOH A2068 26.816 14.614 21.522 1.00 58.30 O HETATM 2290 O HOH A2069 47.836 14.353 58.668 1.00 47.17 O HETATM 2291 O HOH A2070 50.783 8.605 51.257 1.00 48.23 O HETATM 2292 O HOH A2071 48.653 9.006 57.534 1.00 48.22 O HETATM 2293 O HOH A2072 50.875 7.787 55.197 1.00 47.09 O HETATM 2294 O HOH A2073 51.270 4.400 50.901 1.00 40.01 O HETATM 2295 O HOH A2074 46.513 -4.043 51.746 1.00 23.94 O HETATM 2296 O HOH A2075 49.220 -2.089 48.736 1.00 38.19 O HETATM 2297 O HOH A2076 41.438 -6.352 54.095 1.00 27.83 O HETATM 2298 O HOH A2077 39.736 0.294 60.578 1.00 24.89 O HETATM 2299 O HOH A2078 36.955 -6.694 58.381 1.00 40.86 O HETATM 2300 O HOH A2079 27.274 -9.346 40.523 1.00 39.82 O HETATM 2301 O HOH A2080 26.863 -9.220 44.481 1.00 23.61 O HETATM 2302 O HOH A2081 42.822 -12.292 49.863 1.00 53.20 O HETATM 2303 O HOH A2082 51.091 -4.389 51.397 1.00 35.82 O HETATM 2304 O HOH A2083 50.739 -2.038 55.769 1.00 49.50 O HETATM 2305 O HOH A2084 27.607 -4.937 42.674 1.00 18.27 O HETATM 2306 O HOH A2085 49.470 0.539 56.096 1.00 40.10 O HETATM 2307 O HOH A2086 23.602 -14.759 53.122 1.00 42.95 O HETATM 2308 O HOH A2087 20.999 -14.390 52.613 1.00 62.73 O HETATM 2309 O HOH A2088 23.228 -7.923 41.026 1.00 75.56 O HETATM 2310 O HOH A2089 17.288 -1.133 48.144 1.00 32.46 O HETATM 2311 O HOH A2090 24.021 12.564 50.219 1.00 34.75 O HETATM 2312 O HOH A2091 26.134 9.565 48.211 1.00 16.82 O HETATM 2313 O HOH A2092 31.011 12.452 53.950 1.00 20.75 O HETATM 2314 O HOH A2093 25.688 11.266 57.576 1.00 40.16 O HETATM 2315 O HOH A2094 30.259 16.238 55.954 1.00 37.50 O HETATM 2316 O HOH A2095 35.940 -5.784 63.633 1.00 43.20 O HETATM 2317 O HOH A2096 33.235 -2.676 65.424 1.00 31.29 O HETATM 2318 O HOH A2097 37.459 0.045 67.860 1.00 34.83 O HETATM 2319 O HOH A2098 37.169 -2.186 68.978 1.00 39.56 O HETATM 2320 O HOH A2099 42.237 -7.062 63.179 1.00 37.27 O HETATM 2321 O HOH A2100 43.598 -4.626 66.482 1.00 40.39 O HETATM 2322 O HOH A2101 29.040 -5.769 61.737 1.00 29.14 O HETATM 2323 O HOH A2102 33.199 -6.321 64.262 1.00 41.15 O HETATM 2324 O HOH A2103 23.053 3.199 60.108 1.00 25.81 O HETATM 2325 O HOH A2104 20.295 4.451 59.584 1.00 44.52 O HETATM 2326 O HOH A2105 24.247 9.333 55.725 1.00 46.19 O HETATM 2327 O HOH A2106 19.953 2.284 58.097 1.00 52.38 O HETATM 2328 O HOH A2107 22.270 0.949 58.323 1.00 30.27 O HETATM 2329 O HOH A2108 29.856 21.308 51.322 1.00 51.04 O HETATM 2330 O HOH A2109 26.722 19.514 51.826 1.00 37.36 O HETATM 2331 O HOH A2110 29.733 12.012 41.835 1.00 16.42 O HETATM 2332 O HOH A2111 33.110 13.657 52.520 1.00 26.44 O HETATM 2333 O HOH A2112 26.699 12.143 47.279 1.00 22.24 O HETATM 2334 O HOH A2113 24.621 8.578 46.066 1.00 18.43 O HETATM 2335 O HOH A2114 18.848 14.629 46.837 1.00 56.59 O HETATM 2336 O HOH A2115 25.181 7.283 43.583 1.00 20.91 O HETATM 2337 O HOH A2116 22.082 2.717 37.938 1.00 21.98 O HETATM 2338 O HOH A2117 17.028 10.418 39.836 1.00 37.85 O HETATM 2339 O HOH A2118 15.011 3.266 42.565 1.00 48.34 O HETATM 2340 O HOH A2119 13.407 7.327 34.435 1.00 43.95 O HETATM 2341 O HOH A2120 17.178 -1.663 40.995 1.00 74.64 O HETATM 2342 O HOH A2121 22.995 -1.671 36.426 1.00 47.24 O HETATM 2343 O HOH A2122 26.339 -3.688 40.334 1.00 20.48 O HETATM 2344 O HOH A2123 20.182 -3.188 40.614 1.00 30.78 O HETATM 2345 O HOH A2124 25.704 5.236 46.984 1.00 16.46 O HETATM 2346 O HOH A2125 39.044 14.392 51.672 1.00 39.05 O HETATM 2347 O HOH A2126 41.234 12.032 51.492 1.00 37.00 O HETATM 2348 O HOH A2127 35.372 12.138 46.210 1.00 18.66 O HETATM 2349 O HOH A2128 35.397 14.706 52.473 1.00 35.17 O HETATM 2350 O HOH A2129 44.237 10.055 52.492 1.00 35.28 O HETATM 2351 O HOH A2130 47.672 10.079 49.313 1.00 35.29 O HETATM 2352 O HOH A2131 40.324 13.513 43.974 1.00 49.04 O HETATM 2353 O HOH A2132 41.069 14.619 52.910 1.00 62.66 O HETATM 2354 O HOH A2133 39.116 17.558 42.760 1.00 46.65 O HETATM 2355 O HOH A2134 38.556 18.926 44.789 1.00 56.96 O HETATM 2356 O HOH A2135 38.288 18.040 48.837 1.00 43.50 O HETATM 2357 O HOH A2136 33.555 13.363 44.631 1.00 19.67 O HETATM 2358 O HOH A2137 32.837 22.937 45.421 1.00 31.69 O HETATM 2359 O HOH A2138 29.211 21.729 48.357 1.00 25.63 O HETATM 2360 O HOH A2139 27.075 18.853 47.372 1.00 24.79 O HETATM 2361 O HOH A2140 26.572 25.828 41.765 1.00 32.45 O HETATM 2362 O HOH A2141 25.328 20.795 47.637 1.00 36.68 O HETATM 2363 O HOH A2142 26.983 27.218 46.563 1.00 20.28 O HETATM 2364 O HOH A2143 23.028 23.769 46.757 1.00 44.44 O HETATM 2365 O HOH A2144 24.144 25.489 39.963 1.00 52.22 O HETATM 2366 O HOH A2145 20.062 14.330 41.513 1.00 38.81 O HETATM 2367 O HOH A2146 20.585 21.338 42.806 1.00 44.79 O HETATM 2368 O HOH A2147 31.385 24.156 43.225 1.00 34.13 O HETATM 2369 O HOH A2148 35.302 18.555 40.224 1.00 31.43 O HETATM 2370 O HOH A2149 35.872 18.148 37.337 1.00 39.93 O HETATM 2371 O HOH A2150 37.865 15.480 39.038 1.00 37.00 O HETATM 2372 O HOH A2151 33.660 10.129 28.056 1.00 31.13 O HETATM 2373 O HOH A2152 32.715 11.589 26.322 1.00 49.20 O HETATM 2374 O HOH A2153 30.425 14.399 23.941 1.00 52.24 O HETATM 2375 O HOH A2154 32.078 10.155 23.794 1.00 46.86 O HETATM 2376 O HOH A2155 25.336 11.158 21.234 1.00 37.69 O HETATM 2377 O HOH A2156 31.089 2.525 24.396 1.00 28.57 O HETATM 2378 O HOH A2157 28.160 2.651 21.987 1.00 39.35 O HETATM 2379 O HOH A2158 21.155 3.789 31.200 1.00 43.02 O HETATM 2380 O HOH A2159 22.949 1.689 27.940 1.00 48.31 O HETATM 2381 O HOH A2160 17.746 6.485 28.557 1.00 40.83 O HETATM 2382 O HOH A2161 20.656 12.134 20.527 1.00 50.60 O HETATM 2383 O HOH A2162 12.873 11.649 28.736 1.00 56.48 O HETATM 2384 O HOH A2163 18.715 7.680 23.367 1.00 37.76 O HETATM 2385 O HOH A2164 15.648 17.173 30.131 1.00 45.24 O HETATM 2386 O HOH A2165 15.664 19.249 34.406 1.00 41.38 O HETATM 2387 O HOH A2166 19.675 18.811 33.911 1.00 42.47 O HETATM 2388 O HOH A2167 17.672 14.767 38.287 1.00 41.18 O HETATM 2389 O HOH A2168 26.074 14.701 24.443 1.00 46.21 O HETATM 2390 O HOH A2169 23.119 15.745 22.406 1.00 42.83 O HETATM 2391 O HOH A2170 13.345 18.842 32.374 1.00 84.52 O HETATM 2392 O HOH A2171 26.411 22.361 23.338 1.00 54.76 O HETATM 2393 O HOH A2172 25.940 17.742 24.495 1.00 67.01 O HETATM 2394 O HOH A2173 30.122 22.479 23.884 1.00 48.62 O HETATM 2395 O HOH A2174 37.286 18.521 29.959 1.00 35.19 O HETATM 2396 O HOH A2175 37.191 20.192 26.352 1.00 41.51 O HETATM 2397 O HOH A2176 39.305 11.197 32.768 1.00 39.67 O HETATM 2398 O HOH A2177 43.944 15.450 30.115 1.00 70.29 O HETATM 2399 O HOH A2178 48.202 13.047 32.365 1.00 27.22 O HETATM 2400 O HOH A2179 52.475 4.282 42.145 1.00 50.47 O HETATM 2401 O HOH A2180 48.755 2.337 44.128 1.00 39.12 O HETATM 2402 O HOH A2181 48.790 -1.912 43.769 1.00 33.78 O HETATM 2403 O HOH A2182 51.413 1.590 44.340 1.00 49.22 O HETATM 2404 O HOH A2183 47.208 0.915 31.386 1.00 25.67 O HETATM 2405 O HOH A2184 48.746 -3.837 42.011 1.00 26.67 O HETATM 2406 O HOH A2185 35.805 5.271 32.964 1.00 36.76 O HETATM 2407 O HOH A2186 35.547 -2.033 31.265 1.00 41.41 O HETATM 2408 O HOH A2187 33.649 7.388 32.707 1.00 32.94 O HETATM 2409 O HOH A2188 32.589 5.630 30.396 1.00 23.36 O HETATM 2410 O HOH A2189 30.267 3.976 29.861 1.00 34.05 O HETATM 2411 O HOH A2190 26.899 -2.469 36.459 1.00 24.71 O HETATM 2412 O HOH A2191 25.429 -5.938 32.077 1.00 56.53 O HETATM 2413 O HOH A2192 20.801 1.864 32.573 1.00 60.48 O HETATM 2414 O HOH A2193 29.359 -5.263 35.090 1.00 42.44 O HETATM 2415 O HOH A2194 27.990 -1.854 38.926 1.00 17.33 O HETATM 2416 O HOH A2195 31.020 -6.368 36.261 1.00 26.51 O HETATM 2417 O HOH A2196 29.881 -9.304 37.806 1.00 45.43 O HETATM 2418 O HOH A2197 28.090 -7.601 42.716 1.00 18.50 O HETATM 2419 O HOH A2198 34.072 -11.901 40.047 1.00 50.75 O HETATM 2420 O HOH A2199 41.584 -10.151 43.475 1.00 37.07 O HETATM 2421 O HOH A2200 47.951 -5.990 43.620 1.00 40.18 O HETATM 2422 O HOH A2201 44.214 -11.735 47.621 1.00 65.27 O HETATM 2423 O HOH A2202 52.597 -5.781 47.528 1.00 44.08 O HETATM 2424 O HOH A2203 48.695 -4.136 50.095 1.00 25.82 O HETATM 2425 O HOH A2204 48.049 -10.520 49.575 1.00 52.17 O HETATM 2426 O HOH A2205 50.329 -4.458 54.124 1.00 26.34 O HETATM 2427 O HOH A2206 46.816 -8.955 56.360 1.00 35.68 O HETATM 2428 O HOH A2207 45.700 -8.326 59.807 1.00 40.72 O HETATM 2429 O HOH A2208 37.581 -7.095 62.151 1.00 36.40 O HETATM 2430 O HOH A2209 38.506 -10.342 58.621 1.00 47.57 O HETATM 2431 O HOH A2210 40.697 -8.975 61.720 1.00 52.16 O HETATM 2432 O HOH A2211 42.400 -2.734 57.397 1.00 22.35 O HETATM 2433 O HOH A2212 48.093 1.383 58.214 1.00 44.39 O HETATM 2434 O HOH A2213 43.944 0.606 65.344 1.00 48.40 O HETATM 2435 O HOH A2214 46.594 4.901 59.442 1.00 50.55 O HETATM 2436 O HOH A2215 44.486 9.616 62.309 1.00 64.27 O HETATM 2437 O HOH A2216 48.706 11.703 74.147 1.00 62.47 O HETATM 2438 O HOH A2217 30.490 11.639 64.360 1.00 34.80 O HETATM 2439 O HOH A2218 28.024 10.058 62.674 1.00 65.38 O CONECT 2197 2198 2221 CONECT 2198 2197 2199 CONECT 2199 2198 2200 CONECT 2200 2199 2201 2220 CONECT 2201 2200 2202 CONECT 2202 2201 2203 2204 CONECT 2203 2202 CONECT 2204 2202 2205 2208 CONECT 2205 2204 2206 CONECT 2206 2205 2207 CONECT 2207 2206 2208 CONECT 2208 2204 2207 2209 CONECT 2209 2208 2210 CONECT 2210 2209 2211 2212 CONECT 2211 2210 CONECT 2212 2210 2213 2218 CONECT 2213 2212 2214 2215 CONECT 2214 2213 CONECT 2215 2213 2216 CONECT 2216 2215 2217 CONECT 2217 2216 2218 CONECT 2218 2212 2217 2219 CONECT 2219 2218 CONECT 2220 2200 2221 CONECT 2221 2197 2220 MASTER 743 0 1 12 8 0 4 6 2438 1 25 23 END